Literature DB >> 2850886

In situ hybridization analysis of the expression of the type II collagen gene in the developing chicken limb bud.

H D Nah1, B J Rodgers, W M Kulyk, B E Kream, R A Kosher, W B Upholt.   

Abstract

In situ hybridization with [32P]- or [35S]-labeled double-stranded DNA or single-stranded RNA probes was used to investigate the temporal and spatial distribution of cartilage-characteristic type II collagen mRNA during embryonic chick limb development and cartilage differentiation in vivo. When the type II collagen probes were hybridized to sections through embryonic limb buds at the earliest stages of their development (stages 18-25), an accumulation of silver grains representing type II collagen mRNA first became detectable in the proximal central core of the limb coincident with the prechondrogenic condensation of mesenchymal cells that characterizes the onset of cartilage differentiation. At later stages of development (stage 32; 7 days) intense hybridization signals with the type II collagen probes were localized over the well differentiated cartilage rudiments, whereas few or no silver grains above background were observed over the non-chondrogenic tissues. In contrast, sections hybridized with a probe complementary to mRNA for the alpha 1 chain of type I collagen exhibited an intense hybridization signal over the perichondrium and little or no signal over the cartilage primordia. At all stages of development examined, [32P]-labeled double-stranded DNA probes or single-stranded RNA probes labeled with either [32P] or [35S] provided adequate hybridization signals. Several experimental protocols were employed to control for the potential cross-hybridization and non-specific hybridization of the type II collagen probes. These included the utilization of labeled noncomplementary "sense-strand" type II collagen RNA as a control probe for nonspecific background, and prehybridization with a large excess of appropriate unlabeled RNA to block sequences in heterologous collagen RNAs that might cross-hybridize to the specific labeled probe.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2850886     DOI: 10.1016/s0174-173x(88)80001-3

Source DB:  PubMed          Journal:  Coll Relat Res        ISSN: 0174-173X


  8 in total

1.  Distinct roles of type I bone morphogenetic protein receptors in the formation and differentiation of cartilage.

Authors:  H Zou; R Wieser; J Massagué; L Niswander
Journal:  Genes Dev       Date:  1997-09-01       Impact factor: 11.361

Review 2.  FGF signaling in the developing endochondral skeleton.

Authors:  David M Ornitz
Journal:  Cytokine Growth Factor Rev       Date:  2005-04-01       Impact factor: 7.638

3.  Subepithelial type II collagen deposition during embryonic chick limb development.

Authors:  Frédéric Mallein-Gerin
Journal:  Rouxs Arch Dev Biol       Date:  1990-03

4.  Analyses of early events during chondrogenic repair in rat full-thickness articular cartilage defects.

Authors:  Yoshihisa Anraku; Hiroshi Mizuta; Akira Sei; Satoshi Kudo; Eiichi Nakamura; Kei Senba; Yuji Hiraki
Journal:  J Bone Miner Metab       Date:  2009-02-13       Impact factor: 2.626

5.  Development and regeneration of the neonatal digit tip in mice.

Authors:  Manjong Han; Xiaodong Yang; Jangwoo Lee; Christopher H Allan; Ken Muneoka
Journal:  Dev Biol       Date:  2007-12-27       Impact factor: 3.582

Review 6.  Fibroblast growth factor signaling in skeletal development and disease.

Authors:  David M Ornitz; Pierre J Marie
Journal:  Genes Dev       Date:  2015-07-15       Impact factor: 11.361

7.  Prospective isolation of chondroprogenitors from human iPSCs based on cell surface markers identified using a CRISPR-Cas9-generated reporter.

Authors:  Amanda Dicks; Chia-Lung Wu; Nancy Steward; Shaunak S Adkar; Charles A Gersbach; Farshid Guilak
Journal:  Stem Cell Res Ther       Date:  2020-02-18       Impact factor: 8.079

8.  Type IV collagen mRNA accumulates in the mesenchymal compartment at early stages of murine developing intestine.

Authors:  P Simon-Assmann; F Bouziges; J N Freund; F Perrin-Schmitt; M Kedinger
Journal:  J Cell Biol       Date:  1990-03       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.